Rifampin 150 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7NAZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,244
Award facts
- Contract value 100% obligated
- $1,244.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rifampin 150 mg capsules (30-count packaging) under a firm fixed-price contract valued at $1,244.26. The order, issued on December 17, 2025, with an ultimate completion date of December 18, 2025, represents a non-competitive delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. Rifampin is a critical antibiotic commonly used in treating tuberculosis and other mycobacterial infections, making this procurement essential for military healthcare operations. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order is a child action issued under AmerisourceBergen's substantial $1 billion indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen, one of the nation's largest pharmaceutical distributors, maintains a significant role in the Defense Health Agency's supply chain by providing a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. The firm fixed-price delivery order structure reflects the competitive nature of federal pharmaceutical procurement and AmerisourceBergen's established capability to fulfill urgent medical supply requirements efficiently.
Quick answers
Who was awarded contract SPE2DR26F7NAZ?
SPE2DR26F7NAZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F7NAZ worth?
The government has obligated $1,244 on SPE2DR26F7NAZ.
Is contract SPE2DR26F7NAZ an order under another contract?
Yes. SPE2DR26F7NAZ is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7NAZ competed?
The extent of competition for SPE2DR26F7NAZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award